IMEXHS LIMITED — Proxy Solicitation & Information Statement 2007

10 April 2007

biodiesel doesn't cost the earth

Dear fellow shareholder

Your vote is important to success of the Rights Issue

I am writing to remind you of the importance of your vote regarding the approval of the Non-Renouncable Rights Issue, as announced by ABG Limited on 23 March 2007. Details of the Extraordinary General Meeting. to be held on 27 April 2007, to seek approval for the Rights Issue, were mailed to every shareholder in late March.

The two resolutions requiring shareholder approval at the meeting are: Resolution 1- pro rata rights issue approval of the ratio of shares Resolution 2- general approval of the rights issue

The key points I would like to highlight in this matter are:

• Large (substantial) shareholders, including sub-underwriter Transfield Infrastructure Pty Ltd, are excluded from voting in resolution 1, so the participation of smaller shareholders is vital and will influence the outcome of the resolutions put to shareholders.
• ABG Limited's revised business strategy is expected to significantly improve the performance of the ٠ company, however the new business strategy can only be implemented if the funds from the proposed Rights Issue are available.
• If shareholders do not approve the resolutions regarding the Rights Issue, the company will have $\bullet$ inadequate funds from existing operations nor an immediate alternative source of funds to meet its financial commitments to enable the continuation of the business. In those circumstances, the Directors will need to consider the immediate future of ABG Limited, including putting the company into administration.

The Independent Directors of ABG Limited unanimously recommend that shareholders vote in favour of both resolution 1 and resolution 2 approving the Rights Issue. Please submit your Proxy by 10:00am, 25 April 2007, either by mail or by fax, as detailed on the Proxy Form. Your vote is important.

If you have misplaced your Proxy and require a replacement Notice of Meeting and Proxy Form, or have questions about this matter, please call our shareholder inquiry line on 1300 855 307 or +61 2 8256 3373. I would like to thank you for your ongoing support of the company.

Yours sincerely

John Keniry Chairman